⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1975123 | 0.62 | — | — | |
| SCHEMBL6926731 | 0.61 | — | — | |
| SCHEMBL7221349 | 0.60 | — | — | |
| SCHEMBL309011 | 0.60 | — | — | |
| Cytosine SCHEMBL308339 | 0.60 | — | — | |
| SCHEMBL9534465 | 0.57 | — | — | |
| SCHEMBL166600 | 0.56 | — | — | |
| SCHEMBL4411570 | 0.56 | — | — | |
| SCHEMBL10860675 | 0.55 | — | — | |
| SCHEMBL9535338 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1308452-B1 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2008-03-19 | — | — | EP | claimed |
| US-7282581-B2 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2007-10-16 | — | — | US | claimed |
| US-20030118999-A1 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2003-06-26 | — | — | US | claimed |
| EP-1308452-A2 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2003-05-07 | — | — | EP | claimed |
| US-7491818-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2009-02-17 | — | — | US | disclosed |
| US-7423143-B2 | Nucleic acid labeling compounds | AFFYMETRIX. INC. (US) | 2008-09-09 | — | — | US | disclosed |
| EP-1308452-B1 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2008-03-19 | — | — | EP | disclosed |
| US-7291463-B2 | Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis | AFFYMETRIX, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| US-7282327-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7282581-B2 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2007-10-16 | — | — | US | disclosed |
| US-20070154894-A1 | Labeling and non-enzymatic fragmentation of cDNA using a ribonucleoside triphosphate analog | AFFYMETRIX, INC. (US) | 2007-07-05 | — | — | US | disclosed |
| US-7179905-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-20030118999-A1 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2003-06-26 | — | — | US | disclosed |
| EP-1308452-A2 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2003-05-07 | — | — | EP | disclosed |
| US-20020165372-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2002-11-07 | — | — | US | disclosed |
| WO-2000006771-A9 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2002-08-22 | — | — | WO | disclosed |
| US-20010044531-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2001-11-22 | — | — | US | disclosed |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. | 2001-08-30 | — | — | US | disclosed |
| EP-1124838-A2 | NUCLEIC ACID LABELING COMPOUNDS | Affymetrix, Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000006771-A2 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. (US) | 2000-02-10 | — | — | WO | disclosed |